Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02414308Not ApplicableUnknown

Management of Peyronie's Disease With Adipose Tissue Stem Cell

Role: lead

NCT02414295Not ApplicableCompleted

Sperm Production in Kleinfelter Syndrome Patients After Mesenchymal Stem Cell Injection

Role: lead

NCT02008799Not ApplicableUnknown

Intra Testicular Artery Injection of Bone Marrow Stem Cell in Management of Azoospermia

Role: lead

NCT02028013Unknown

Management of Sexual Dysfunction With Bioresonance Technique

Role: lead

All 4 trials loaded